Discontinuation report TELZIR
| Report ID | 238356 |
| Drug Identification Number | 02261553 |
| Brand name | TELZIR |
| Common or Proper name | Fosamprenavir oral suspension 50 mg/mL |
| Company Name | VIIV HEALTHCARE ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | FOSAMPRENAVIR |
| Strength(s) | 50MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 225 ml |
| ATC code | J05AE |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2024-12-31 |
| Remaining supply date | 2024-05-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-877-393-8448 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2025-03-19 | French | Compare |
| v7 | 2025-03-19 | English | Compare |
| v6 | 2025-01-02 | French | Compare |
| v5 | 2025-01-02 | English | Compare |
| v4 | 2024-09-23 | French | Compare |
| v3 | 2024-09-23 | English | Compare |
| v2 | 2024-09-23 | French | Compare |
| v1 | 2024-09-23 | English | Compare |
Showing 1 to 8 of 8